참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Water | HCID 962 | — |
| 반응물 | Sodium hydride | HCID 24758 | — |
| 반응물 | Ethyl 3-{[(tert-butoxy)carbonyl]amino}propanoate | HCID 15933116 | — |
| 반응물 | HCID 178449909 | HCID 178449909 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | [2-(3-Propyl-[1,2,4]oxadiazol-5-yl)-ethyl]-carbamic acid tert-butyl ester | HCID 57466817 | — |
반응 단계
N-Hydroxy-butyramidine (0.425 g, 4.16 mmol) in DMF (2 ml) is added to a stirred suspension of sodium hydride (0.183 g of a 60% dispersion in oil, 4.58 mmol) in the presence of molecular sieves (0.4 g). The reaction flask is then immersed in a pre-heated oil bath at 50° C. and stirring continued for 5 min. 3-tert-Butoxycarbonylamino-propionic acid ethyl ester (0.904 g, 4.16 mmol) in DMF (2 ml) is added over 5 min followed by more DMF (2 ml). After 3 h at 50° C. the mixture is cooled to 0° C. and water (3 ml) is added. The mixture is allowed to warm to room temperature then filtered through Celite™ filter material, washing with ethyl acetate, and the solvent is removed. Purification by chromatography, eluting with DCM:MeOH (95:5 increasing to 85:15) affords the titled compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07902375B2 |
|---|
| 출처 데이터셋 | uspto-grants-2011_03 |
|---|
| ORD ID | ord-7c4b4ec3643944bea55102e646b2ee01 |
|---|
| 출처 메모 | uspto-grants-2011_03 |
|---|